Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NYSE /
  3. BLCO.NYSE

Bausch + Lomb Corp (BLCO NYSE) stock market data APIs

$15.59 -0.22(-1.4%) as of July 26, 2024
Price chart is built with Anychart

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. Its Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation operates as a subsidiary of Bausch Health Companies Inc.

Bausch + Lomb Corp Financial Data Overview

15.81
15.59
-
15.81
15.36
13.16-20.3
5 484 M
351 M
4 314 M
0.472
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'BLCO',
Type: 'Common Stock',
Name: 'Bausch + Lomb Corp',
Exchange: 'NYSE',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG014KG1L68',
ISIN: 'CA0717051076',
CUSIP: NULL,
CIK: '1860742',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2022-05-06',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Medical Instruments & Supplies',
HomeCategory: NULL,
IsDelisted: false,
}

Bausch + Lomb Corp Fundamental Data is available in our Financial Data APIs

  • Net Revenue 4 314 M
  • EBITDA 613 M
  • Earnings Per Share -0.96
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Bausch + Lomb Corp Earnings via APIs

  • Latest Release 2024-07-31
  • EPS/Forecast 0.12

Get Bausch + Lomb Corp End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Bausch + Lomb Corp latest news via APIs

Bausch + Lomb Will Release Second-Quarter 2024 Financial Results on July 31

VAUGHAN, Ontario, July 11, 2024--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release it...

Millions of Americans Experience Dry Eye Symptoms, Yet New National Survey Shows Sufferers Struggle to Find Relief

New Online Resource, KnowYourDryEye.com, Aims to Increase Awareness and Education VAUGHAN, Ontario, July 08, 2024--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye he...
Do you have any questions?
support@eodhistoricaldata.com